|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiovascular Disease |
Estudio Rio de la Plata, Buenos Aires, Argentina
Objective: To identify and to analyze the risk factor by cardiac
hypertrophy in patients on peritoneal dialysis (PD).
Methods: Patients aged >18 on PD >3 months were enrolled. Patients
with cancer, liver chronic disease, IES, rheumatic or congenital heart disease
were excluded. 124 PD patients by Rio de la Plata Registry were analyzed. Left
ventricular mass index (LVMi), RGF rate, CRP, hemoglobin, albumin, and BP were
determined. LVH (g/m2) was defined as LVMi >47 women and >50
men. Inflammation as denoted by CRP>2.6 mg/L.
Results: Statistical Analysis: STATA 7.0. t-Test, MannWhitney or
KruskalWallis test was used. 92% had LVI; 69% had CRP>2.6. Age:
50±14.3 years; dialysis time: 24 (1048) months; smoking history
15%; diabetes 26%; coronary artery disease 18.6%; atherosclerotic disease 22%.
On erythropoietin 77%; history BP 83%; systolic BP: 125±17; diastolic
BP: 80±12.8; LVMi: 92 (70143); BMI: 26 (2330); Hb:
11±2.46; with RRF 61%; RGF rate: 2.1 (03.7). LVMi was positively
correlated with Hb<9 (p>0.02) and previous HD: odds ratio 3.24
(p>0.005), CI (1.47.6). NS difference LVMi groups RRF,
CRP<2.6 and no RRF, CRP>2.6. All comparisons were adjusted by BP, sex,
age, previous HD.
Conclusions: LVMi was correlated with Hb<9 and previous HD. NS
difference LVMi groups with RRF, CRP<2.6 and no RRF, CRP>2.6.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |